Navigation Links
Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
Date:3/7/2012

(March 7, 2012) HOBOKEN, NJ Half the population experiences menopause, and for those women, it is a condition they will experience for approximately one third of their lifetime. Alternative or natural remedies are an easy, effective way to improve signs and symptoms linked to the menopausal transition, without side effects. Natural supplement Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, was found to significantly improve signs and symptoms of menopause in a recent clinical trial published in Panminerva Medica.

The study was conducted at Pescara University and examined 70 perimenopausal women, aged 40-50 years. Perimenopause is the term used to describe the menopause transition years, typically the years before and after the final menstrual period. Participants were assigned to a placebo or test group. The test group was given 100 mg of Pycnogenol per day (50 mg taken twice daily), over a period of eight weeks. Participants' menopausal symptoms were evaluated by a scoring system, based on a total of 33 common signs and symptoms, using values ranging from zero (absent) to a maximum of four (very serious). Oxidative stress levels were evaluated by measuring capillary blood plasma free radicals from a drop of capillary blood from the finger tips.

The study found that:

  • Pycnogenol substantially improved perimenopausal signs and symptoms including hot flashes, night sweats, mood swings, irregular periods, loss of libido and vaginal dryness after eight weeks of treatment, as judged by patients' scores, showing a decrease from an average of 2.67/4 to 1.45/4
  • Pycnogenol effectively decreased the severity of hot flashes, decreased bloating and improved irregular heart beat and improved digestive problems
  • Menopausal symptoms categorized under "pain" improved significantly with the group taking Pycnogenol
  • Oxidative stress levels decreased significantly after Pycnogenol supplementation, improving quality of life and helping to control signs and symptoms of menopause

"As evidenced by this study, Pycnogenol may arguably represent a very effective basic, daily dietary supplement for menopausal women due to its extended range of health benefits, including cardiovascular benefits and Pycnogenol's proven ability to lower blood pressure," says Dr. Gianni Belcaro, the lead researcher from Pescara University, Italy.

Results showed that not only did Pycnogenol improve menopausal signs and symptoms, but also decreased elevated levels of oxidative stress, as shown by capillary blood tests. Pycnogenol's ability to manage heart health is of particular significance as menopausal women live at elevated risk for cardiovascular disease.

This study confirms previous findings that Pycnogenol effectively improves perimenopausal signs and symptoms. A previous study in Taiwan investigated 200 mg of Pycnogenol in 200 perimenopausal women over a period of half a year and identified an improvement in most signs and symptoms. This study demonstrated Pycnogenol's ability to improve signs and symptoms not only with a smaller dosage of Pycnogenol but also over a shorter period of time.


'/>"/>

Contact: Katherine Davis
kdavis@mww.com
312-981-8549
MWW Group
Source:Eurekalert

Related biology news :

1. Pycnogenol (French maritime pine bark extract) shown to improve visible signs of aging in new study
2. Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan
3. ComCam Selected by ePortation on New Maritime Domain Awareness Project
4. ComCam Selected by ePortation on New Maritime Domain Awareness Project
5. Stevens and TNO to collaborate on maritime security
6. National Center for Secure and Resilient Maritime Commerce releases annual report
7. New ways to chart our maritime past
8. NOAA, Spain announce cooperative arrangement to preserve maritime underwater heritage
9. Ultrasound shown to exert remote control of brain circuits
10. Dictyostelium cells shown to lay breadcrumb trail as first step in multicellular formation
11. Twin nanoparticle shown effective at targeting, killing breast cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)...  Blueprint Bio, a company dedicated to identifying, protecting ... has closed its Series A funding round, according to ... "We have received a commitment from Forentis Fund that ... meet our current goals," stated Matthew Nunez . ... complete validation on the current projects in our pipeline, ...
Breaking Biology Technology: